Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02702388
Title Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 20 mg or 14 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Facility#1 La Jolla California 92093 United States Details
Facility #1 San Diego California 92307 United States Details
Facility #1 Torrance California 90502 United States Details
Facility #1 Washington District of Columbia 20010 United States Details
Facility #1 Boston Massachusetts 02114 United States Details
Facility #2 Boston Massachusetts 02115 United States Details
Facility #1 Ann Arbor Michigan 48109 United States Details
Facility #1 Detroit Michigan 48201 United States Details
Facility#2 Morristown New Jersey 07962 United States Details
Facility#1 Summit New Jersey 07902 United States Details
Facility #1 Bronx New York 10461 United States Details
Facility #1 Columbus Ohio 43210 United States Details
Facility #1 Portland Oregon 97239 United States Details
Facility #2 Philadelphia Pennsylvania 19104 United States Details
Facility #1 Philadelphia Pennsylvania 19111 United States Details
Facility #1 Seattle Washington 98109 United States Details
Facility #1 Darlinghurst New South Wales Australia Details
Facility #1 Saint Leonards New South Wales Australia Details
Royal Brisbane and Women's Hospital Brisbane Queensland 4006 Australia Details
Facility#2 Chermside Queensland Australia Details
Facility #1 Herston Queensland Australia Details
Facility #1 Melbourne Victoria Australia Details
Facility #1 Nedlands Western Australia Australia Details
Facility #1 Melbourne Australia Details
Facility #1 Saint Leonards Australia Details
Facility #1 Edegem Antwerpen 2650 Belgium Details
Facility #1 Bruxelles Brussels 1200 Belgium Details
Facility #2 Namur 5000 Belgium Details
Facility #1 Namur Belgium Details
Facility #1 Calgary Alberta Canada Details
Facility #1 Toronto Ontario Canada Details
Facility #1 Quebec Canada Details
Facility #1 Odense Syddanmark DK-5000 Denmark Details
Facility #1 Strasbourg Bas-Rhin France Details
Facility #1 Caen Calvados 14076 France Details
Facility #1 Dijon Cote-d'Or 21079 France Details
Facility #1 Bordeaux Gironde France Details
Facility #1 Angers Maine-et-Loire France Details
Facility #2 Villejuif Val-de-Marne 94805 France Details
Facility #1 Villejuif Val-de-Marne France Details
Facility #2 Angers 49933 France Details
Facility #1 Bordeaux 33076 France Details
Facility #1 Caen France Details
Facility #1 Dijon 21079 France Details
Facility #2 Lyon 69373 France Details
Facility #1 Paris 75013 France Details
Facility #1 Tubingen Baden-Wurttemberg 72076 Germany Details
Facility #1 Wurzburg Bayern 97080 Germany Details
Facility #1 Hannover Niedersachsen 30625 Germany Details
Facility #1 Essen Nordrhein-Westfalen Germany Details
Facility #2 Essen Nordrhein-Westfalen Germany Details
Facility #1 Essen 45147 Germany Details
Facility #1 Leipzig Germany Details
Facility #1 Petach Tikva Israel Details
Facility #6 Roma Lazio 144 Italy Details
Facility #1 Roma Lazio Italy Details
Facility #2 Roma Lazio Italy Details
Facility #3 Roma Lazio Italy Details
Facility #2 Milano Lombardia Italy Details
Facility #3 Milano Lombardia Italy Details
Facility #4 Milano Lombardia Italy Details
Facility #5 Milano Lombardia Italy Details
Facility #1 Livorno Toscana 57100 Italy Details
Facility #1 Pisa Toscana Italy Details
Facility #6 Milano 20122 Italy Details
Facility #7 Milano 20149 Italy Details
Facility #2 Pisa 56124 Italy Details
Facility #4 Roma Italy Details
Facility #2 Rozzano Italy Details
Facility #1 Torino Italy Details
Facility #1 Viagrande Italy Details
Facility#1 Busan 49241 Korea, Republic of Details
Facility #1 Goyang-si Korea, Republic of Details
Facility #3 Seoul 135-710 Korea, Republic of Details
Facility #4 Seoul 137-701 Korea, Republic of Details
Facility #1 Seoul Korea, Republic of Details
Facility #2 Seoul Korea, Republic of Details
Facility #2 Kielce Poland Details
Facility #1 Cluj-Napoca Cluj 400058 Romania Details
Facility #1 Bucharest 11863 Romania Details
Facility #4 Saint Petersburg Leningradskaya O 197758 Russian Federation Details
Facility #3 Moscow 115478 Russian Federation Details
Facility #4 Moscow 117036 Russian Federation Details
Facility #1 Moscow Russian Federation Details
Facility #2 Moscow Russian Federation Details
Facility #1 Obninsk 249036 Russian Federation Details
Facility #3 Saint Petersburg 197758 Russian Federation Details
Facility #1 Saint Petersburg Russian Federation Details
Facility #2 Saint Petersburg Russian Federation Details
Facility #1 Barcelona Cataluna Spain Details
Facility #2 Madrid Madrid, Communidad Delaware Spain Details
Facility #1 Badalona 8035 Spain Details
Facility #2 Barcelona 8036 Spain Details
Facility #1 Madrid 28034 Spain Details
Facility #2 Madrid Spain Details
Facility #3 Madrid Spain Details
Facility #1 Malaga 29010 Spain Details
Facility #1 Goteborg SE-41345 Sweden Details
Facility #1 Lund SE-22185 Sweden Details
Facility #1 London City Of London United Kingdom Details
Facility #1 Glasgow Glasgow City United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field